The Infectious Diseases Data Observatory (IDDO) is a scientifically independent, multi-disciplinary coalition of the global infectious disease and emerging infections communities. It provides the methods, governance and infrastructure to translate data into evidence that improves outcomes for patients worldwide. Currently, IDDO has eight active areas of research with many more already in development or being scoped for feasibility.
Share data

If you work with clinical, laboratory or epidemiological data and want to share your research or access research data then you are welcome to sign up to the Observatory.

We have platforms for a range of diseases including emerging and neglected infections.

Learn about our approach and governance
Learn about our research themes
What is IDDO?

The Infectious Diseases Data Observatory (IDDO) is a researcher driven network which provides data platforms to capture, share and collaborate on infectious disease related data.

Using years of experience and extensive investment in data tools we provide platforms which are designed for effective data analysis and robust governance.

Find out more about IDDO

COVID-19

Explore our work on COVID-19

Sars cov2 causes covid19
View

Research themes

IDDO enables research-driven responses to major challenges of infectious diseases through development and management of data sharing platforms.

Credit: Wellcome Images
Research themes

Contributing data

Learn more about sharing your data through IDDO

Connected world
Contribute data

Tools and resources

IDDO is committed to providing practical tools and services to support the collection of disease characterisation data and develop quality evidence on optimal treatment and response to emerging infections. 

Credit: MORU
View our resources

News

Blurred people on a busy street
i
CREDIT: Mauro Mora
News Article
29 Jul 2021
Preprints: it’s time to agree on terminology and best practice
pills
i
istock
News Article
23 Jul 2021
Track regulatory and WHO alerts on our substandard and falsified medical products tool
BSP 2021 logo
i
Credit Gonzalo Sanchez-Arsuaga
News Article
20 May 2021
Join IDDO at this year’s BSP Conference in June
ANTICOV logo
News Article
27 Apr 2021
ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination
View all news items

Latest publications

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

The Lancet Infectious Diseases

Published: 22 Sep 2023

Author(s): Megha Rajasekhar, Prof Julie A Simpson, Benedikt Ley, Peta Edler, Cindy S Chu, Tesfay Abreha, Ghulam R Awab, Prof J Kevin Baird, Germana Bancone, Bridget E Barber, Matthew J Grigg, Jimee Hwang, Harin Karunajeewa, Prof Marcus V G Lacerda, , Simone Ladeia-Andrade, Prof Alejandro Llanos-Cuentas, Prof Sasithon Pukrittayakamee, Komal R Rijal, Kavitha Saravu, Prof Inge Sutanto, Walter R J Taylor, Kamala Thriemer, James A Watson, Prof Philippe J Guerin, Prof Nicholas J White, Prof Ric N Price, Rob, on behalf of theWorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group

DOI: https://doi.org/10.1016/S1473-3099(23)00431-0

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis

The Lancet Infectious Diseases

Published: 22 Sep 2023

Author(s): Robert J Commons, Megha Rajasekhar, Peta Edler, Tesfay Abreha, Ghulam R Awab, Prof J Kevin Baird, Bridget E Barber, Cindy S Chu, Prof Liwang Cui, André Daher, Lilia Gonzalez-Ceron, Matthew J Grigg, Jimee Hwang, Harin Karunajeewa, Prof Marcus V G Lacerda, , Simone Ladeia-Andrade, Kartini Lidia, Prof Alejandro Llanos-Cuentas, Rhea J Longley, Dhelio B Pereira, Ayodhia P Pasaribu, Prof Sasithon Pukrittayakamee, Komal R Rijal, Prof Inge Sutanto, Walter R J Taylor, Pham V Thanh, Kamala Thriemer, , José Luiz F Vieira, James A Watson, Lina M Zuluaga-Idarraga, Nicholas J White, Prof Philippe J Guerin, Prof Julie A Simpson, Prof Ric N Price, , on behalf of theWorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group

DOI: https://doi.org/10.1016/S1473-3099(23)00430-9

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

The Lancet Infectious Diseases

Published: 22 Sep 2023

Author(s): Megha Rajasekhar, Prof Julie A Simpson, Benedikt Ley, Peta Edler, Cindy S Chu, Tesfay Abreha, Ghulam R Awab, Prof J Kevin Baird, Germana Bancone, Bridget E Barber, Matthew J Grigg, Jimee Hwang, Harin Karunajeewa, Prof Marcus V G Lacerda, Simone Ladeia-An

DOI: https://doi.org/10.1016/S1473-3099(23)00431-0

View all publications